Sivextro approved for adult skin infections

Sivextro approved for adult skin infections

(HealthDay)—The antibiotic Sivextro (tedizolid phosphate) has been approved by the U.S. Food and Drug Administration to treat adults with skin infections.

The drug, which may be taken intravenously or orally as a pill, is designed to treat infections including methicillin-resistant Staphylococcus aureus (MRSA), the FDA said in a news release.

The drug's safety and effectiveness were evaluated in clinical studies involving more than 1,300 adults with serious-to-severe . The most common side effects recorded were nausea, headache, diarrhea, vomiting and dizziness. The drug was not evaluated among adults with neutropenia, the agency said.

Sivextro is the second new antibiotic for skin infections to be FDA-approved in the past month, following the May 23 approval of Dalvance (dalbavancin).

Sivextro is marketed by Cubist Pharmaceuticals, baaed in Lexington, Mass.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Vibativ approved for certain bacterial pneumonia

Jun 24, 2013

(HealthDay)—The antibiotic Vibativ (telavancin) has been approved by the U.S. Food and Drug Administration to treat pneumonia caused by Staphylococcus aureus bacteria when other treatments aren't suitable.

Impavido approved to treat tropical parasitic disease

Mar 20, 2014

(HealthDay)—Impavido (miltefosine) has been approved by the U.S. Food and Drug Administration to treat adults with leishmaniasis, a tropical disease caused by a parasite that's transmitted by the bites of sand flies.

Aptiom approved to treat seizures

Nov 11, 2013

(HealthDay)—Aptiom (eslicarbazepine acetate) has been approved by the U.S. Food and Drug Administration as an add-on drug to help treat adults with partial epileptic seizures.

Recommended for you

Experts want restrictions on testosterone drug use (Update)

12 hours ago

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...

Big cities take aim at prescription painkillers

Sep 16, 2014

Some of the nation's largest cities are ratcheting up their criticism of prescription painkillers, blaming the industry for a wave of addiction and overdoses that have ravaged their communities and busted local budgets.

World Health Organization policy improves use of medicines

Sep 16, 2014

In this issue of PLOS Medicine, Kathleen Holloway from WHO and David Henry (University of Toronto, Canada) evaluated data on reported adherence to WHO essential medicines practices and measures of quality use of medicines from 5 ...

User comments